Post-translational modification signature shapes the tumor immune microenvironment and predicts clinical outcomes in melanoma
Discover Oncology · 10.04.2026 · 17 (1)
DOI: 10.1007/s12672-026-04477-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 10.04.2026. Verfasst von Tianmei Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The People's Hospital of Pingyang, Wenzhou, China. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, The People's Hospital of Pingyang, Wenzhou, China.
- Department of Neurosurgery, The People Hospital of Xin Chang, No.117 Gushan Middle Road, Nanming Street, Xin Chang, 312500, Zhejiang, China. 634152662@qq.com.
- Department of Neurology, The People Hospital of Xin Chang, No.117 Gushan Middle Road, Nanming Street, Xin Chang, 312500, Zhejiang, China. 17357596898@163.com.
Zitieren
APA
Lin, T., Fu, B., & Lu, X. (2026). Post-translational modification signature shapes the tumor immune microenvironment and predicts clinical outcomes in melanoma. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-04477-4
Vancouver
Lin T, Fu B, Lu X. Post-translational modification signature shapes the tumor immune microenvironment and predicts clinical outcomes in melanoma. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-04477-4
BibTeX
@article{Lin2026,
author = {Lin, Tianmei and Fu, Biao and Lu, Xia},
title = {Post-translational modification signature shapes the tumor immune microenvironment and predicts clinical outcomes in melanoma},
journal = {Discover Oncology},
year = {2026},
volume = {17},
number = {1},
doi = {10.1007/s12672-026-04477-4}
}
EUVIMED